NeuroOne Medical Technologies Publishes Initial Clinical Results For Its OneRF Trigeminal Nerve Ablation System
Benzinga Newsdesk 2 days ago
News
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on the surgical diagnosis and treatment of neurological disorders, today
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on the surgical diagnosis and treatment of neurological disorders, today announced the publication of initial clinical results evaluating its OneRF® Trigeminal Nerve Ablation System in the peer-reviewed journal Pain Management.